Medicare Compliance & Reimbursement - 2014 Issue 11
Reader Question: Stick To Pathology Dx for ICD-9 Choice
Subscribe or sign in to view the full article.
Article Overview
This reader Q&A addresses coding for a breast pathology report when the wording appears inconsistent with the finding reported. It discusses how the issue is handled in ICD-9 and how ICD-10 offers more specific breast-related diagnosis options, making the topic relevant to coders, billers, and compliance staff working with pathology and oncology-related documentation.
Why This Topic Matters
Pathology reports can contain wording that is clinically and administratively confusing, and coding accuracy depends on recognizing how diagnosis terminology maps to the applicable code set. The article helps readers understand the broader challenge of selecting diagnosis codes when documentation language is not straightforward, especially across the ICD-9 to ICD-10 transition.
Article Sections
-
Question
Introduces a reader question about a breast pathology report and the coding uncertainty it creates. The focus is on how documentation language and diagnosis terminology can affect code selection.
-
Answer
Explains the coding perspective for the reported breast finding and notes the need for clarification when pathology language appears contradictory. It also contrasts the older ICD-9 framework with the more specific ICD-10 approach for related breast diagnoses.
What You Will Learn
- How ambiguous pathology wording can affect diagnosis coding decisions
- How breast-related findings were addressed in ICD-9 versus ICD-10
- Why clarification of contradictory documentation may be appropriate
- What kinds of guidance are used when coding pathology-driven diagnosis scenarios
Who Should Read This
- Medical coders
- Coding auditors
- Compliance staff
- Revenue cycle professionals
- Pathology billing staff
- Oncology coding professionals
Codes Discussed
Subscribe or sign in to view the full article.


Quick, Current, Complete - www.findacode.com